What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary areas of investigation include Lymphoma, Pathology, Lymphomatoid papulosis, CD30 and Cancer research.
His Lymphoma study deals with the bigger picture of Internal medicine.
Marshall E. Kadin combines subjects such as Gene rearrangement, Clone and Antigen with his study of Pathology.
His study in Lymphomatoid papulosis is interdisciplinary in nature, drawing from both Anaplastic large-cell lymphoma, Lymphoproliferative disorders and Surgery.
His studies deal with areas such as Relative risk and Cohort study as well as CD30.
His Cancer research research incorporates elements of Cell culture and Receptor, Transforming growth factor beta, Signal transduction, Transforming growth factor.
His most cited work include:
- Detection of Clonal T-Cell Receptor |[gamma]| Gene Rearrangements in Early Mycosis Fungoides/Sezary Syndrome by Polymerase Chain Reaction and Denaturing Gradient Gel Electrophoresis (PCR/DGGE) (319 citations)
- Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. (287 citations)
- Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy (276 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Pathology, Lymphoma, CD30, Lymphomatoid papulosis and Cancer research.
The various areas that Marshall E. Kadin examines in his Pathology study include T cell and Immunophenotyping.
The study incorporates disciplines such as Surgery and Disease in addition to Lymphoma.
His CD30 research is multidisciplinary, incorporating perspectives in Reed–Sternberg cell, T-cell lymphoma and CD8.
His Lymphomatoid papulosis study deals with Pathogenesis intersecting with Virus.
His Cancer research study combines topics from a wide range of disciplines, such as Cell culture, Apoptosis, JUNB, Signal transduction and Anaplastic large-cell lymphoma.
He most often published in these fields:
- Pathology (58.86%)
- Lymphoma (52.53%)
- CD30 (29.75%)
What were the highlights of his more recent work (between 2004-2017)?
- Cancer research (26.58%)
- Pathology (58.86%)
- Lymphoma (52.53%)
In recent papers he was focusing on the following fields of study:
Marshall E. Kadin mainly investigates Cancer research, Pathology, Lymphoma, Lymphomatoid papulosis and CD30.
His studies in Cancer research integrate themes in fields like Anaplastic large-cell lymphoma, JUNB, Growth factor receptor inhibitor and Lymphocyte.
His research integrates issues of Natural history and CD8 in his study of Pathology.
His Lymphoma study is associated with Internal medicine.
His biological study spans a wide range of topics, including Dermatology, Lymphoproliferative disorders and Programmed cell death.
The Oncology study combines topics in areas such as Immunology, Karyotype, Cohort and Chromosomal translocation.
Between 2004 and 2017, his most popular works were:
- Long-Term Results of CCG 5942: A Randomized Comparison of Chemotherapy With and Without Radiotherapy for Children With Hodgkin's Lymphoma—A Report From the Children's Oncology Group (107 citations)
- The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. (81 citations)
- The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. (81 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Marshall E. Kadin mainly focuses on Lymphoma, Anaplastic large-cell lymphoma, Cancer research, Anaplastic lymphoma kinase and Large-cell lymphoma.
All of his Lymphoma and Lymphomatoid papulosis and CD30 investigations are sub-components of the entire Lymphoma study.
Marshall E. Kadin has researched Lymphomatoid papulosis in several fields, including Cell, Lymphoproliferative disorders, T cell, Stem cell and Transforming growth factor beta.
His CD30 study integrates concerns from other disciplines, such as CD30 Ligand, Transforming growth factor, Growth inhibition and Receptor complex.
Anaplastic large-cell lymphoma is the subject of his research, which falls under Pathology.
The concepts of his Pathology study are interwoven with issues in Immunophenotyping, Antigen and Lymphocyte.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
